encyclopedia of medical concepts
ψ
ψ
Phospholipases
More information
in Books
or on
Definition
: A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.
Examples
Lysophospholipase
;
Phospholipases A
Other names
Lecithinases; Phospholipase; Lecithinase
Substance
CAS Registry & name
Categories
Source
Drugs
*
DDHD2 protein, human
EC 3.1.1.-
*Phospholipases.
Oncogene 2009 Apr 30;28(17):1892-903
Abh4 protein, mouse
EC 1.14.11.-
*Phospholipases.
J Biol Chem 2006 Sep 8;281(36):26465-72
Hev b 4 allergen, Hevea brasiliensis
EC 3.1.-
*Phospholipases
*Antigens, Plant
Glycoproteins.
Clin Exp Allergy 2005 Nov;35(11):1490-5
phospholipase IVC, Arabidopsis
EC 3.1.-
*Phospholipases
*Arabidopsis Proteins.
Plant Physiol 2002 Sep;130(1):90-101
phospholipase IVA, Arabidopsis
EC 3.1.-
*Phospholipases
*Arabidopsis Proteins.
Plant Physiol 2002 Sep;130(1):90-101
phospholipase IIA, Arabidopsis
EC 3.1.-
*Phospholipases
*Arabidopsis Proteins.
Plant Physiol 2002 Sep;130(1):90-101
SGR2 protein, Arabidopsis
EC 3.1.-
*Phospholipases
*Arabidopsis Proteins.
Plant Cell 2002 Jan;14(1):33-46
2-
chloro-
3-
((4-
ethyl-
phenyl)-
amino)-
1,4-
naphthalendione
0
*Naphthalenes
Phospholipases/antagonists & inhibitors.
Res Commun Mol Pathol Pharmacol 1999 ;104(2):165-72
1-
thio-
octyl-
2-
heptylphosphonyl-
1-
deoxyglycero-
3-
phosphoglycol
0
*Phospholipids
Phospholipases/antagonists & inhibitors.
Nat Struct Biol 1995 May;2(5):402-3
diepoxin sigma
152697-41-1 Spiro(2a,6a-
epoxynaphth(2,3-
b)oxirene-
2(1aH),2'-
naphtho(1,8-
de)(1,3)dioxin)-
3,7(6H,7aH)-
dione, 6-
hydroxy-
,(1aS-
(1aalpha,2abeta,6alpha,6abeta,7aalpha))
*Epoxy Compounds
*Spiro Compounds
Phospholipases/antagonists & inhibitors.
Anticancer Drug Des 1994 Aug;9(4):363-72
SCH 49210
151702-60-2 Spiro02a,6a-
epoxynaphth(02,3-
b)oxirene-
2(7H),(((2'-
naphtho01,8-
de)01,3)dioxin)-
7-
one, 1a,3,4,5,6,7a-
hexahydro-
3,6-
dihydroxy-
, (1aalpha,2abeta,3alpha,6alpha,6abeta,7aalpha)
*Epoxy Compounds
*Spiro Compounds
Phospholipases/antagonists & inhibitors.
Anticancer Drug Des 1994 Aug;9(4):363-72
AGN 190383
120755-15-9
*Furans
Phospholipases/antagonists & inhibitors.
Agents Actions 1991 Sep;34(1-2):70-72
Notechis 11'2
120930-83-8
*Elapid Venoms
Phospholipases.
Eur J Biochem 1991;202(2):493
TMVPLA2 II
EC 3.1.-
*Phospholipases
Crotalid Venoms.
J Pharm Pharmacol 1990;42(12):846
TMVPLA2 I
EC 3.1.-
*Phospholipases.
J Pharm Pharmacol 1990;42(12):846
scutoxin A
132444-97-4 Scutoxin A
*Elapid Venoms
Phospholipases.
Toxicon 1991;29(1):85
ammodytoxin A
97089-72-0
*Viper Venoms
Phospholipases.
FEBS Lett 1991;280(1):175
methionyl-
leucyl-
phenylalanyl-
isoleucyl-
lysyl-
arginyl-
seryl-
arginyl-
histidyl-
phenylalanine
92237-18-8 L-
Phenylalanine, N-
(N-
(N2-
(N-
(N2-
(N2-
(N-
(N-
(N-
(N-
(N-
L-
methionyl-
L-
leucyl)-
L-
phenylalanyl)-
L-
isoleucyl)-
L-
leucyl)-
L-
isoleucyl)-
L-
lysyl)-
L-
arginyl)-
L-
seryl)-
L-
arginyl)-
L-
histidyl)-
, (SP-
4-
2)
*Peptide Fragments
Phospholipases/antagonists & inhibitors.
Arch Biochem Biophys 1985;236(1):195
notechis 5
0
*Elapid Venoms
Phospholipases.
Clin Exp Pharmacol Physiol 5(6):587;1978; J Biol Chem 251(23):7343;1976; J Neurochem 31(4):969;1978